(20S)-Protopanaxatriol
CAS No. 34080-08-5
(20S)-Protopanaxatriol ( 20(S)-APPT | g-PPT )
产品货号. M18440 CAS No. 34080-08-5
(20S)-原人参三醇(g-PPT)是人参皂苷的代谢产物,可通过雌激素受体和糖皮质激素受体调节内皮细胞功能。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥454 | 有现货 |
|
| 10MG | ¥658 | 有现货 |
|
| 25MG | ¥1097 | 有现货 |
|
| 50MG | ¥1758 | 有现货 |
|
| 100MG | ¥2673 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥500 | 有现货 |
|
生物学信息
-
产品名称(20S)-Protopanaxatriol
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述(20S)-原人参三醇(g-PPT)是人参皂苷的代谢产物,可通过雌激素受体和糖皮质激素受体调节内皮细胞功能。
-
产品描述(20S)-Protopanaxatriol(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor.
-
体外实验(20S)-Protopanaxatriol works through the glucocorticoid receptor (GR) and oestrogen receptor (ER) in human umbilical vein endothelial cells (HUVECs). (20S)-Protopanaxatriol (PPT) increases [Ca2+]i with an EC50 of 482 nM in HUVECs. ((20S)-Protopanaxatriol (1 μM) elevates NO production via ERβ. (20S)-Protopanaxatriol inhibits the autonomous transactivation of Gal4-LXRα LBD, the T0901317-dependent transcription of SREBP-1c and its promoter. (20S)-Protopanaxatriol (10 μg/mL) blocks the recruitment of RNA polymerase II to the LXRE region of SREBP-1c. (20S)-Protopanaxatriol also inhibits T0901317-dependent transcription of LXRα target genes related to lipogenesis, and reduces T0901317-induced cellular triglyceride (TG) accumulation in primary hepatocytes, but does not alter transcription of ABCA1, also an LXRα target gene.Both In HCC827GR and H1975 cell lines, g-PPT (100?nM, 1?μM, 10?μM, 20?μM; 48 hours) results in SCD1 expression decreased.
-
体内实验(20S)-Protopanaxatriol (10?mg/kg; i.p.; daily for four weeks) synergizes with Gefitinib to inhibit xenograft growth.(20S)-Protopanaxatriol (50-100 mg/kg; p.o.; 25 days; female BALB/c nude mice bearing breast cancer MCF-7 cell) inhibits the growth of MCF-7 breast cancer cells in a nude mice xenograft assay. Animal Model:H1975 murine xenograft tumor model Dosage:10?mg/kg Administration:I.p.; daily for four weeks Result:The combined g-PPT and Gefitinib (50 mg/kg/day) treatment clearly reduced p-EGFR and KI67 expression and increased c-Caspase3 expression compared to Gefitinib or g-PPT treatment alone.
-
同义词20(S)-APPT | g-PPT
-
通路Cell Cycle/DNA Damage
-
靶点DNA/RNA Synthesis
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number34080-08-5
-
分子量476.73
-
分子式C30H52O4
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 47 mg/mL;98.59 mM
-
SMILESC1C[C@@H](C([C@@H]2[C@H](C[C@]3([C@@]4(CC[C@@H]([C@H]4[C@@H](C[C@@H]3[C@@]12C)O)[C@](C)(CCC=C(C)C)O)C)C)O)(C)C)O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Zhang Y, et al. Sci Rep. 2014 Dec 9;4:7375.
产品手册
关联产品
-
Docosanoic acid
二十二烷酸是一种长链饱和脂肪酸。它存在于花生油和油橄榄籽油中。
-
RP-6685
RP-6685是一种有效且具有选择性和口服活性的 DNA 聚合酶 θ (Polθ) 抑制剂,其 IC50 值为5.8 nM (PicoGreen 实验)。RP-6685 在小鼠肿瘤移植模型中表现出抗肿瘤作用。
-
Treosulfan
Treosulfan 是一种双功能烷化剂。它还对卵巢癌和其他实体瘤类型具有活性。
021-51111890
购物车()
sales@molnova.cn

